In tumor-related studies, DDR2 is upregulated in a variety of cancer cells, and DDR2 is a major regulator of EMT, promoting the EMT process in cancers such as breast cancer (40, 41), liver cancer (28), and thyroid cancer (29). The gene discussed is DDR2; the disease is breast cancer.